Pharmacoeconomics 2011; 29(5): 439–54PubMedCrossRef 2 Parashar U

Pharmacoeconomics 2011; 29(5): 439–54PubMedCrossRef 2. Parashar UD, Hummelman EG, Bresee JS, et al. Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis 2003 May; 9(5): 565–72PubMedCrossRef 3. Leung AK, Kellner JD, Davies HD. Rotavirus gastroenteritis. Adv Ther 2005 Sep 31; 22(5): 476–87PubMedCrossRef 4. Cortese MM, Parashar UD, Centers for Disease Control and Prevention (CDC). Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep

2009 Feb 6; 58(RR-2): 1–25PubMed 5. Parashar UD, Alexander JP, Glass RI. Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee HSP990 molecular weight on Immunization Practices (ACIP). MMWR Recomm Rep 2006 Aug 11; 55(RR-12): 1–13PubMed 6. Gray J, Vesikari T, Van Damme P, et al. Rotavirus. J Pediatr Gastroenterol Nutr 2008 May; 46 Suppl. 2: S24–31PubMedCrossRef 7. Clark HF, Offit PA. Vaccines NU7026 order for rotavirus gastroenteritis universally needed for infants. Pediatr Ann 2004 Aug; 33(8): 536–43PubMed 8. Parashar UD, Gibson CJ, Bresse JS, et al. Rotavirus and severe childhood diarrhea. Emerg Infect Dis 2006 Feb;

12(2): 304–6PubMedCrossRef 9. Soriano-Gabarro M, Mrukowicz J, Vesikari T, et al. Burden of rotavirus disease in European Union countries. Tenoxicam Pediatr Infect Dis J 2006; 25 Suppl. 1: S7–11PubMed 10. Bhan MK, Lew JF, Sazawal S, et al. Protection

conferred by check details neonatal rotavirus infection against subsequent rotavirus diarrhea. J Infect Dis 1993 Aug; 168(2): 282–7PubMedCrossRef 11. Velazquez FR, Matson DO, Calva JJ, et al. Rotavirus infections in infants as protection against subsequent infections. N Engl J Med 1996 Oct 3; 335(14): 1022–8PubMedCrossRef 12. Bishop RF, Barnes GL, Cipriani E, et al. Clinical immunity after neonatal rotavirus infection: a prospective longitudinal study in young children. N Engl J Med 1983 Jul 14; 309(2): 72–6PubMedCrossRef 13. Velazquez FR. Protective effects of natural rotavirus infection. Pediatr Infect Dis J 2009 Mar; 28 (3 Suppl.): S54–6PubMed 14. Santos N, Hoshino Y. Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine. Rev Med Virol 2005; 15(1): 29–56PubMedCrossRef 15. Van Damme P, Giaquinto C, Maxwell M, et al. Distribution of rotavirus genotypes in Europe, 2004–2005: the REVEAL study. J Infect Dis 2007 May 1; 195 Suppl. 1: S17–25PubMedCrossRef 16. Diez-Domingo J, Baldo JM, Patrzalek M, et al. Primary care-based surveillance to estimate the burden of rotavirus gastroenteritis among children aged less than 5 years in six European countries. Eur J Pediatr 2011; 170(2): 213–22PubMedCrossRef 17. Vesikari T, Van Damme P, Giaquinto C, et al.

Comments are closed.